Expert Consultations: Real-World Answers

Nociceptive Pain Syndromes: Focus on Fibromyalgia – Interview

Published on February 1, 2024 Certification expiration date: February 1, 2027

Guest

Wegdan Rashad

To unlock this audio you need to become a Silver, Gold, Silver extended or Gold extended Member.

Check Our CME Program

Downloads for Offline Access

Download Audio File (MP3)

Interview Highlights

A core management strategy for nociplastic pain is improving sleep and enhancing physical activity.
Excessive endogenous opioids may play a role in the pathogenesis of nociplastic pain syndromes. Hence, giving such patients opioids may worsen the condition in the long run.
Neuromodulation strategies, such as TENS, TMS, and transcutaneous vagal nerve stimulators, may be helpful in the management of nociplastic pain syndromes.

Text Version

This edition of Psychopharmacology Institute’s Expert Consultations features Daniel Clauw, M.D., Professor of Anesthesiology, Medicine, and Psychiatry at the University of Michigan. Dr. Clauw leads the Chronic Pain and Fatigue Research Center in the Department of Anesthesiology at the University of Michigan. In this interview, we will discuss nociplastic pain syndromes, including fibromyalgia.

Wegdan Rashad, M.D.: Dr.

Unlock this Expert Consultation and earn 0.75 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.

Get Instant Access

Already have an account? Sign in

Learning Objectives:

Understand essential management strategies for nociplastic pain.
Identify the neurobiological mechanisms that underpin nociplastic pain syndromes, which can direct treatment.
Evaluate the presence of neuroplastic pain syndromes clinically and using rating scales.

Original Release Date: February 1, 2024

Review and Re-release Date: March 1, 2024

Expiration Date: February 1, 2027

Expert: Daniel Clauw, M.D.

Medical Editors: Wegdan Rashad, M.D., Melissa Mariano, M.D.

Relevant Financial Disclosures:

Daniel Clauw declares the following interests:

- Viatris, Tonix, Ono, Lilly: Consultant

All of the relevant financial relationships listed above have been mitigated by Medical Academy and the Psychopharmacology Institute.

None of the other faculty, planners, and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Daniel J. Clauw, M.D.